GL1X · GenesisL1 explorer

MolNFT v1 · #177020 · protein

Crystal structure of human microplasmin in complex with kazal-type inhibitor aati

7E50 · AAEL006007-pa: “Crystal structure of human microplasmin in complex with kazal-type inhibitor aati”. X-ray diffraction, 1 ligand (NA), 3 pockets (best druggability 0.39). MolNFT v1 #177020 on GenesisL1: 3D structure, binding sites…

PDB
7E50
Type
protein
Length
300 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
AAEL006007-pa; Plasminogen
EC
3.4.21.7
UniProt
Q1HRB8, P00747
Ligands
NA
Pockets
3 · best druggability 0.39

Structure

x-ray diffraction · 2 distinct chains · 12% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAAEL006007-paprotein5525% helix, 20% strandQ1HRB8
BPlasminogen (EC 3.4.21.7)protein2459% helix, 36% strandP00747

Ligands and binding sites

  • NA · Sodium ion · metal · 3 copies · chains B
  • GOL · Glycerol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11300.390.7421empty
21010.360.7422empty
3520.300.7613GOL, NA

Interfaces

1 interface between chains.

  • A–B · 638 Ų buried · 18 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 9 disulfide (disulfide).

Compared structures

  • 7E50 · Crystal structure of human microplasmin in complex with kazal-type inhibitor AaTI · the same entry in another collection · chain A against A, TM-score 1.00
  • P00747 · AlphaFold monomer V2.0 prediction for plasminogen (P00747) · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.